Eichler, Florian et al "Interim Results from a Phase 2/3 Study of the Efficacy and Safety of Ex Vivo Gene Therapy With Lentiviral Vector (Lenti-D) for Childhood Cerebral Adrenoleukodystrophy (PL02.002)." Neurology 86.16 Supplement (2016): PL02.002. Web. 02 Oct. 2022.